| Literature DB >> 26353810 |
Edvin Prifti1, Fadil Ademaj2, Arben Baboci3, Aurel Demiraj4.
Abstract
The Gerbode's defect is a communication between the left ventricle and right atrium. It is usually congenital, but rarely is acquired, as a complication of endocarditis, myocardial infarction, trauma, or after previous cardiac surgery. The acquired Gerbode defect with involvement of the tricuspid valve acquired after bacterial endocarditis can be challenging to repair. We present a rare case of young woman, with endocarditis of the tricuspid valve and acquired Gerbode defect without previous cardiac surgery. She underwent successful surgical closure of the Gerbode defect and reconstruction of the septal leaflet of the tricuspid valve using a an autologous pericardial patch. A total of 20 other cases were reported with acquired Gerbode defect due to endocarditis in patients without previous cardiac surgery. Three other cases presented acquired Gerbode defect due to myocardial infarction and two due to chest trauma. Another series of 62 patients presented acquired Gerbode defect after previous cardiac surgery. Surgical treatment is always feasible with excellent outcome. However the percutanous transcatheter closure remains an excellent option especially in high risk patients.Entities:
Mesh:
Year: 2015 PMID: 26353810 PMCID: PMC4565022 DOI: 10.1186/s13019-015-0320-z
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1a Transesophageal echocardiography demonstrating the shunt between the left ventricle and right atrium. b Transthoracic echocardiography demonstrating the vegetation inserted above the septal leaflet of the tricuspid valve. c Cardiac magnetic resonance demonstrating a communication between the left ventricle and right atrium and right ventricle according to (d). C-type acquired Gerbode defect representing a supravalvular combined with n infravalvular communication between the left and right side of the heart
Fig. 2a Intraoperative view demonstrating the acquired Gerbode defect after removing the septal leaflet and part of the anterior leaflet of the tricuspid valve. b A diagram representing the extension of the destructed valvular tissue. c Hydraulic maneuver after closure of the acquired Gerbode defect and reconstruction of the septal leaflet of the tricuspid valve. d A diagram demonstrating the final view of the operation
Patients with acquired Gerbode defect without prior cardiac surgery
| Author (Ref) | Year | Gender/Age | Location | Bacteria | Diagnosis | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
| 1. Battin [ | 1991 | Male/15 | na | na | TTE | Surgery | Survived |
| 2. Saiki [ | 1994 | Male/42 | MV,AV | Streptococcus hemolyticus | TTE, | Surgery | Survived |
| 3. Katoh [ | 1994 | Male/58 | TV | na | na | Surgery | Survived |
| 4. Elian [ | 1995 | Male/64 | TV | Staphylococcus aureus | TTE, TEE, CC | Surgery | Survived |
| 5. Velebit [ | 1995 | Male/ 30 | BAV | Staphylococcus aureus | TEE, CC | Surgery | Survived(AVB) |
| 6. Winslow [ | 1995 | Male/ 30 | AV | Staphylococcus aureus | TTE, TEE | Surgery | Survived |
| 7. Michel [ | 1996 | Male/52 | AV | Streptococcus viridans | TTE, TEE | Conservative | Survived |
| 8. Alphonso [ | 2003 | Male/ 63 | AV | Culture negative | TTE | Surgery | Survived |
| 9. Raja [ | 2006 | Male/47 | RA | Staphylococcus aureus | TTE, TEE | Surgery | Survived(RF) |
| 10. Fukui [ | 2007 | Male/57 | TV, AV, MV | na | TEE | Surgery | Survived |
| 11. Tatewaki [ | 2008 | Female/7 | TV, AV, MV | Staphylococcus aureus | TEE, CT | Surgery | Survived |
| 12. Inouel [ | 2009 | Female/21 | AV | Culture negative | TTE, TEE | Surgery | Survived |
| 13. Cortez-Dias [ | 2009 | Male/59 | MV | Staphylococcus aureus | TTE, TEE | Conservative | Died(AVB, RF) |
| 14. Mendoza [ | 2009 | Female/52 | AV | Streptococcus mutans | TTE, CT | Surgery | Survived |
| 15. Hori [ | 2010 | Male/41 | BAV | na | TTE | Surgery | Survived |
| 16. Matt [ | 2010 | Male/35 | AV | Hemophilus aphrophilus | TTE,TEE | Surgery | Survived(AVB) |
| 17. Ota [ | 2011 | Male/71 | AV | Streptococcus pneumonia | TTE,TEE | Surgery | Survived |
| 18. Pillai [ | 2011 | Male/12 | TV | Culture negative | TEE | Surgery | Survived |
| 19. Carpenter [ | 2012 | Male/22 | TV | Staphylococcus lugdunensis | TEE, CT | Surgery | Survived |
| 20. Hsu [ | 2014 | Male/40 | BAV | Cardiobacterium hominis | TEE, | Surgery | Died(RF) |
| 21. Prifti et al. | 2015 | Female/40 | TV | Staphylococcus aureus | TTE, TEE | Surgery | Survived |
| Area of myocardial infarction | |||||||
| 22. Hole [ | 1995 | Male/63 | Inferior myocardial infarction | TTE | Surgery | Survived | |
| 23. Jobic [ | 1997 | Female/72 | Inferior myocardial infarction | TTE, TEE | Surgery | Died (RF) | |
| 24. Newman [ | 1996 | Male/72 | Inferior myocardial infarction Trauma | TTE, TEE | Surgery | Died | |
| 25. Venkatesh [ | 1996 | Male/16 | Blunt trauma | TTE, TEE | Surgery | Survived | |
| 26. Selinger [ | 1998 | Male/70 | Bullet, trauma | TTE,TEE,CC | Surgery | Survived | |
Legend: TTE Transthoracic echocardiography, TEE Transesophageal echocardiography, CC Cardiac catheterization, CT Cardiac tomography, na not available, AV Aortic valve, BAV Bicuspid Aortic Valve, MV Mitral valve, TV Tricuspid valve, RF Renal Failure, AVB Complete atrioventricular block
Patients with acquired Gerbode defect undergoing previous cardiac surgery
| Author | Year | Gender | Age | Diagnostic tool | Previous procedure | Treatment | Outcome |
|---|---|---|---|---|---|---|---|
| 1. Katta et al. | 1994 | Male | 54 | TTE,TEE | Endomyocardial biopsy | Conservative | Survived |
| 2. Dzwonczyk et al. | 1995 | Male | 25 | TTE | ASD repair | na | na |
| 3. Dzwonczyk et al. | 1995 | Female | 72 | TTE | AVR, VSD repair | na | na |
| 4. Fukui et al. | 2000 | Male | 53 | TEE | MVR x 2 | Surgery | Survived |
| 5. Benisty et al. | 2000 | Male | 72 | TTE, TEE | MVR | Surgery | n.a. |
| 6. Benisty et al. | 2000 | Male | 73 | TTE, TEE | MVR x 3, AVR | Surgery | n.a. |
| 7. Weinrich et al. | 2001 | Female | 58 | TEE, CC | MVRx 2 | Surgery | Survived |
| 8. Wasserman et al. | 2002 | Male | 78 | TTE, TEE, | AVR | Surgery | Survived |
| 9. Cabalka et al. | 2005 | Female | 70 | TTE, TEE | MVR x 2 | Percutaneous | Survived |
| 10. Lorber et al. | 2006 | Female | 78 | TTE, CC | MVR | Percutaneous | Survived |
| 11. Ramasubbu et al. | 2006 | Male | 41 | TEE | Aortic root reconstruction | Surgery | Survived |
| 12. Ramasubbu et al. | 2006 | Female | 44 | TEE | Aortic root reconstruction | Conservative | Survived |
| 13. Trehan et al. | 2006 | Male | 22 | TTE, MRI, CC | VSD + sinus valsalva repair | Percutaneous | Survived |
| 14. Martinez et al. | 2007 | Female | 70 | TTE | MVR | Percutaneous | Survived |
| 15. Martinez et al. | 2007 | Male | 67 | TTE | AVR | Percutaneous | Survived |
| 16. Uslu et al. | 2007 | Male | 54 | TTE | MVR | Surgery | Survived |
| 17. Hilberath et al. | 2007 | Male | 68 | TEE | AVR + endocarditis | Surgery | Survived |
| 18. Frigg et al. | 2008 | Female | 77 | TEE, CC | AVR | Surgery | Survived |
| 19. Moaref et al. | 2008 | Female | 51 | TEE | MVR | Surgery | na |
| 20. Aoyagi et al. | 2008 | Female | 71 | TTE, CC | MVR, TV repair | Surgery | Survived |
| 21. Rothman et al. | 2008 | Male | 86 | TTE, CC | MVR | Percutaneous | Survived |
| 22. Hansalia et al. | 2009 | Female | 46 | TTE | AVR | Surgery | Survived |
| 23. Yared et al. | 2009 | Male | 60 | TTE, TTE | AVR+ endocarditis | na | na |
| 24. Gorki et al. | 2009 | Female | 69 | na | AVR + endocarditis | na | na |
| 25. Subramaniam et al. | 2009 | Male | 60 | TEE, CT | AVR | Surgery | Survived |
| 26. Amirghofran et al. | 2009 | Female | 51 | TEE | MVR | Surgery | Survived |
| 27. Silbiger et al. | 2009 | Female | 30 | TTE, CC | VSD repair | Conservative | Survived |
| 28. Cheema et al. | 2009 | Female | 31 | MRI | VSD repair | Conservative | Survived |
| 29. Can et al. | 2009 | Male | 72 | TTE | AV nod ablation | Conservative | Survived |
| 30. Can et al. | 2009 | Male | 68 | Autopsy | AV nod ablation | na | Died |
| 31. Dadkhah et al. | 2009 | Female | 73 | TEE | TV repair | Conservative | Survived |
| 32. Mohapatra et al | 2009 | Female | 22 | TEE | MVR (RF) | Surgery | Survived |
| 33. Sun et al. | 2010 | na | na | na | MVR | Surgery | na |
| 34. Sun et al. | 2010 | na | na | na | MVR | na | na |
| 35. Pursnani et al. | 2010 | Male | 78 | TTE, TEE | AVR | Surgery | Survived |
| 36. Sharma et al. | 2011 | Male | 80 | TTE | AV nod ablation | Conservative | Survived |
| 37. Kumar et al. | 2011 | Female | 59 | TEE | AVRx2 + endocarditis | Surgery | Survived |
| 38. Zhu et al. | 2012 | Baby | 6 months | TTE, TEE | ASD, VSD repair | Percutaneous | Survived |
| 39. Bochard-Villanueva | 2012 | Male | 63 | TEE, CT | AVR+ endocarditis | Surgery | Survived |
| 40. Vallakati et al. | 2012 | Female | 53 | TTE | AVR | Conservative | Survived |
| 41. Elmistekawy et al. | 2012 | Male | 59 | TEE | AVR | Surgery | Survived |
| 42. Dores et al. | 2012 | Male | 50 | TTE, TEE | AVR, MVR | Surgery | Survived |
| 43. Yurdakul et al. | 2012 | Male | 68 | TEE | AVR | Surgery | Survived |
| 44. Mousavi et al. | 2012 | Female | 76 | TEE, MRI | AVR | Conservative | Survived |
| 45. Ozdogan et al. | 2012 | Female | 31 | TTE, TEE | MVRx2 + endocarditis | Surgery | Died |
| 46. Anderson et al. | 2012 | na | na | na | AVR | na | na |
| 47. Toprak et al. | 2013 | Male | 32 | TTE, TEE | AVR | Conservative | Survived |
| 48. Notarangelo et al. | 2013 | n.a. | 69 | TTE, TEE | MVR | Percutaneous | Survived |
| 49. Sinisalo et al. | 2013 | Male | 75 | TTE, TEE, CC | AVR | Percutaneous | Survived |
| 50. Sinisalo et al. | 2013 | Female | 23 | TEE, CC | VSD repair | Percutaneous | Survived |
| 51. Sinisalo et al. | 2013 | Male | 10 | TEE, CC | ASD, VSD repair | Percutaneous | Survived |
| 52. Sinisalo et al. | 2013 | Male | 8 | TEE, CC | VSD repair | Percutaneous | Survived |
| 53. Dangol et al. | 2013 | Male | 6 months | TTE,TEE,CC | ToF repair | Percutaneous | Survived |
| 54. Lee et al. | 2013 | Male | 3 months | TTE, CC | ASD, PDA, VSD repair | Percutaneous | Survived |
| 55. Poulin et al. | 2013 | Female | 75 | TTE,TEE | MVR | Percutaneous | Survived |
| 56. Primus et al. | 2013 | Female | 76 | TTE,TEE | AVR | Conservative | Survived |
| 57. Chaturvedi et al. | 2013 | Male | 62 | TTE, MRI | AVR | Percutaneous | Survived |
| 58. Tayama et al. | 2014 | Male | 75 | TTE, CC | MV and TV repair | Surgery | Survived |
| 59. Hussain et al. | 2014 | Male | 45 | TTE, TEE | AVRx2 | Surgery | Survived |
| 60. Chamsi-Pasha et al | 2014 | Male | 67 | TTE, TEE | MVR, TVR | Surgery | Survived |
| 61. Taskesen et al. | 2014 | Male | 74 | TTE, TEE | AVRx2 | Percutaneous | Survived |
| 62. Fanari et al | 2015 | Female | 50 | TTE, CT | AVR | Percutaneous | Survived |
Patients with acquired Gerbode defect undergoing previous cardiac surgery
Legend: TTE Transthoracic echocardiography, TEE Transesophageal echocardiography, CC Cardiac catheterization, CT Cardiac tomography, MRI Magnetic resonance, na-not available, AVR Aortic valve replacement, MVR Mitral valve replacement, TV Tricuspid valve, ASD Atrial septal defect, VSD Ventricular septal defect, ToF Tetralogy of Fallot, PDA Patent ductus arteriosum